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Implant-related infections after the insertion of biomedical implants are still prevalent, and the 
current treatment methodology requires the use of large doses of antibiotics systemically. Large 
doses can lead to a number of side effects including antibiotic resistance and adverse effects on the 
other organs. These infections delay healing, worsen functional outcome and incur significant socio-
economic costs. Bone implant related infections, surgery site infections (SSI), and osteomyelitis 
remain the most challenging clinical problems faced. This thesis aimed to develop a novel implant 
coating system based on a ‘Local and Controlled Antibiotic Delivery System with Biodegradable 
Polymeric Thin Film Composite Coating’ for metallic bone implants.  
The specific aim of this study was to design a novel multi-functional and antibacterial coating for 
implants as the drug delivery systems to prevent post-operative complications and osteomyelitis. 
The main challenge was to obtain the perfect design and the selection of appropriate biomaterials; 
implantable device with antibacterial, biocompatible and bioactive properties. Therefore, 
gentamicin antibiotic (Gm) and Gm loaded coralline hydroxyapatite (HAp) particles were 
incorporated into a poly-lactic acid (PLA) matrix as the main biocomposite.  A number of systems 
were produced, characterized and tested, which included PLA, PLA-Gm mixture, and a PLA-Gm-(HAp-
Gm) biocomposite.  
The coral skeleton (CaCO3) was converted to HAp by using the hydrothermal conversion method. 
These microspheres were loaded with Gm and HAp-Gm particles and incorporated within the PLA 
thin film composites. Coralline-HAp possesses a unique nano- and meso-porous structure and can be 
used as a drug carrier for the sustained release of antibiotics on metallic bone implants. While the 
physiochemical characterizations of the PLA biocomposite coating were evaluated, their Gm release 
profile were analyzed by the continuous dissolution method. The bioactivity and biocompatibility of 
the design was tested on Adipose-derived stem cells using in vitro studies. The antibacterial activity 
and biofilm formation behaviour were also analyzed with S. aureus and S. epidemidis.  
Different Gm concentrations (5%, 10%, 15%, 20% and 30% [w/w]) were incorporated into the PLA 
biocomposites and were found to be highly effective on the inhibition of S. aureus and S. epidermidis 
growth at the planktonic stage. At the biofilm formation stage of S. aureus, the significant reduction 
of bacterial attachment and the increasing of dead microcolonies were observed for even the lowest 
5% (w/w) PLA-Gm-(HAp-Gm) coated samples. This research showed that the biodegradable and 
antibacterial PLA biocomposite coatings design has high potential as a viable alternative method for 
existing clinical applications on many metallic orthopedic and maxillofacial bone implants. 
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Figure 6. 4 Graph depicts the S. aureus growth curves, and the addition of the PLA-Gm-(HAp-Gm) 
coated Ti6Al4V discs during the early exponential phase (two hours after bacterial growth was 
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initiated). Absorbance was measured at 600 nm for twenty-four hours. Statistical analysis performed 
using two-way ANOVA with Tukey’s post-test. n=3. Error bars denote SD. **p<0.01, ****p<0.0001 
Figure 6. 5 Representative fluorescent images S. aureus following twenty-four hours of co-culture 
with Ti6Al4V discs (as indicated). Samples were co-stained with DMOA (live; green) and EtD-III (dead; 
red), merged images are also shown. Scale bar represents 20 µm 
Figure 6. 6 Graph represents the percentage of DMOA-positive (live) S. aureus following twenty-four 
hours of co-culture with the controls (A) (as indicated), and (B) PLA and PLA-Gm-(HAp-Gm) thin film 
coated Ti6Al4V discs (5% to 30% w/w Gm concentrations). The analysis was performed using ImageJ 
software. Statistical analysis performed using one-way ANOVA with Tukey’s post-test. n=3 (15 
images per sample). Error bars denote SEM. *p<0.05, **p<0.01 
Figure 7. 1 The live image of ADSCs in T75 flask (A) and the graph for the cell number and live/dead 
ratio for ADSCs with Trypan blue staining (B) 
Figure 7. 2 SEM images of ADSCs on the  Ti6Al4V disc (A), PLA thin film (B), PLA-HAp thin film (C), 
PLA-Gm (30% w/w) thin film (D), and PLA-Gm-(HAp-Gm) (30% w/w) thin film coated Ti6Al4V discs 
after 14 days experiment 
Figure 7. 3 Bio-plex assay heat map data for ctrl, Ti6Al4V disc, PLA, PLA-HAp, PLA-Gm, and PLA-Gm-
(HAp-Gm) thin film coated Ti6Al4V discs for Day7 and Day 14. (The heat map scale is 2 fold increases 
in above red and 2 fold decreases in below green) 
Figure 7. 4 SEM images of ADSCs on PLA-Gm-(HAp-Gm) (30% w/w) thin film coated Ti6Al4V discs at 
the  5% (A), 10% (B), 15% (C), 20% (D), and 30% (E) (w/w) Gm concentrations after 14 days 
experiment 
Figure 7. 5 Fluorescence staining for Ti6Al4V, PLA coated Ti6Al4V and PLA-Gm-(HAp-Gm) coated 
Ti6Al4V at 5%, 10%, 15%, 20% and 30% Gm with Phalloidin (red, F-actin) and DAPI (blue, cell nuclei) 
Figure 7. 6  Graph represents the comparison of (A) the cell numbers, (B) total cell area %, (C) single 
cell area mm2, and (D) circularity for PLA-Gm-(HAp-Gm) thin film coated Ti6Al4V discs (5% to 30% 
w/w Gm concentrations). The analysis was performed using ImageJ software. Statistical analysis 
performed using one-way ANOVA with Tukey’s post-test. n=3. Error bars denote SEM. P values: 
*p<0.04, **p<0.008, **** p<0.0001 
Figure 7. 7 Fluorescence staining with Phalloidin (red, F-actin) and DAPI (blue, cell nuclei) for ADSCs 
on PLA thin film coated Ti6Al4V (x40) 
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Figure 7. 8 The heat map for the Bioplex assay that includes 27 cytokines (y-axis) and 32 samples (x-
axis), Ti6Al4V disc, PLA thin film coated Ti6Al4V disc, PLA-Gm-(HAp-Gm) thin film coated Ti6Al4V 
discs at predetermined Gm concentrations (5%, 10%, 15%, 20%, and 30%) for D3, 7, 10 and 14 
Figure 7. 9 Graph represents the comparison of (A) the cell numbers, (B) total cell area %, (C) single 
cell area mm2, and (D) circularity for Ti6Al4V and A-Ti6Al4V discs. The analysis was performed using 
ImageJ software. Statistical analysis performed using Student t-test, unpaired , two-tails, n=3, P 
values: * p=0.04, ** p= 0.002 (D) Fluorescence staining with Phalloidin (red, F-actin) and DAPI (blue, 
cell nuclei) for ADSCs on Ti6Al4V and A-Ti6Al4V discs 
Figure 7. 10 The heat map for the Bioplex assay that includes 27 cytokines (y-axis) and 8 samples (x-
axis), untreated Ti6Al4V disc, and anodized Ti6Al4V discs for Day3, 7, 10 and 14 
Figure 7.11 The graphs show the number of total identified gene ontologies biological processes for 
ADSCs which were seeded on Ti6Al4V discs, PLA coated Ti6Al4V discs and PLA-Gm-(HAp-Gm) coated 
Ti6Al4V discs at predetermined Gm concentrations (5%, 10%, 15%, 20% and 30% w/w) 
Figure 7.12 two-way Venn diagram illustrates the identified gene ontology biological processes for 
unique Ti6Al4V, unique PLA coated Ti6Al4V and shared proteins for Ti6Al4V and PLA coated Ti6Al4V 
Figure 7.13 three-way Venn diagram illustrates the identified GO biological processes numbers for 
the comparison of Ti6Al4V, PLA coated Ti6Al4V with 5% (A), 10% (B), 15% (C), 20% (D), and 30% (E) 
PLA-Gm-(HAp-Gm) coated Ti6Al4V samples, separately  
Figure 7.14 five-way Venn diagram illustrates the only unique identified protein numbers for 5% (A), 
10% (B), 15% (C), 20% (D), and 30% (E) PLA-Gm-(HAp-Gm) coated Ti6Al4V samples, separately 
Figure 7.15 Cytoscape protein interaction network graph of proteins identified by mass 
spectrometry. Blue – unique 5%, Red – unique 10%, Green – unique 15%, Purple – unique 20% , 
Orange – unique 30% PLA-Gm-(HAp-Gm) coated Ti6Al4V samples, Yellow – shared Ti6Al4V and PLA 
coated Ti6Al4V, Grey – shared proteins for all 
Figure 7.16 two-way Venn diagram illustrates the protein numbers for unique Anodized Ti6Al4V (A- 
Ti6Al4V), unique untreated Ti6AlV and shared proteins for A-Ti6Al4V and Ti6Al4V 
Figure 7.17 The graphs show the refined number ontologies of proteins identified with direct roles in 
a osteogenic biological process for unique A-Ti6Al4V sample and (B) the shared of Anodized and 
untreated Ti6Al4V samples 
Figure 7.18 Cytoscape protein interaction network graph of the unique A-Ti6Al4V proteins relevant 
to osteogenesis development and antimicrobial activities were identified by mass spectrometry 
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Figure 7.19 Cytoscape protein interaction network graph of proteins identified by mass 
spectrometry. Blue - unique proteins for A-Ti6Al4V, Orange – unique Ti6Al4V (orange), and Green - 
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